메뉴 건너뛰기




Volumn 78, Issue 1, 2007, Pages 108-109

New formulation of Botox: Complete antibody-induced treatment failure in cervical dystonia [9]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BOTULINUM TOXIN A; PROMETHAZINE;

EID: 33846002335     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2006.093419     Document Type: Letter
Times cited : (20)

References (9)
  • 1
    • 0027421580 scopus 로고
    • Botulinum antibodies in dystonic patients treated with type A botulinum toxin: Frequency and significance
    • Zuber M, Sebald M, Bathien N, et al. Botulinum antibodies in dystonic patients treated with type A botulinum toxin: frequency and significance. Neurology 1993;43:1715-18.
    • (1993) Neurology , vol.43 , pp. 1715-1718
    • Zuber, M.1    Sebald, M.2    Bathien, N.3
  • 2
    • 9244247668 scopus 로고    scopus 로고
    • Antibody-induced failure of botulinum toxin type B therapy in de novo patients
    • Dressler D, Bigalke H. Antibody-induced failure of botulinum toxin type B therapy in de novo patients. Eur Neurol 2004;52:132-5.
    • (2004) Eur Neurol , vol.52 , pp. 132-135
    • Dressler, D.1    Bigalke, H.2
  • 3
    • 0037426445 scopus 로고    scopus 로고
    • Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia
    • Jankovic J, Vuong KD, Ahsan J. Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia. Neurology 2003;60:1186-8.
    • (2003) Neurology , vol.60 , pp. 1186-1188
    • Jankovic, J.1    Vuong, K.D.2    Ahsan, J.3
  • 4
    • 1642311191 scopus 로고    scopus 로고
    • New formulation of BOTOX®: Complete antibody-induced therapy failure in hemifacial spasm
    • Dressler D. New formulation of BOTOX®: complete antibody-induced therapy failure in hemifacial spasm. J Neurol 2004;251:360.
    • (2004) J Neurol , vol.251 , pp. 360
    • Dressler, D.1
  • 5
    • 0002052055 scopus 로고
    • The Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS): Assessment of validity and inter-rater reliability
    • Consky ES, Basinski A, Belle L, et al. The Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS): assessment of validity and inter-rater reliability. Neurology 1990;40(Suppl 1):445.
    • (1990) Neurology , vol.40 , Issue.SUPPL. 1 , pp. 445
    • Consky, E.S.1    Basinski, A.2    Belle, L.3
  • 6
    • 0031464004 scopus 로고    scopus 로고
    • Botulinum toxin therapy failure: Causes, evaluation procedures and management strategies
    • Dressler D. Botulinum toxin therapy failure: causes, evaluation procedures and management strategies. Eur J Neurol 1997;4(Suppl 2):S67-S70.
    • (1997) Eur J Neurol , vol.4 , Issue.SUPPL. 2
    • Dressler, D.1
  • 7
    • 0031239673 scopus 로고    scopus 로고
    • Botulinum A toxin: Neutralizing and nonneutralizing antibodies - therapeutic consequences
    • Goeschel H, Wohlfahrt K, Frevert J, et al. Botulinum A toxin: Neutralizing and nonneutralizing antibodies - therapeutic consequences. Exp Neurol 1997;147:96-102.
    • (1997) Exp Neurol , vol.147 , pp. 96-102
    • Goeschel, H.1    Wohlfahrt, K.2    Frevert, J.3
  • 8
    • 0007588785 scopus 로고    scopus 로고
    • Botulinum toxin therapy: Risk factors for therapy failure
    • Dressler D, Dirnberger G. Botulinum toxin therapy: risk factors for therapy failure. Mov Disord 2000;15(Suppl 2):51.
    • (2000) Mov Disord , vol.15 , Issue.SUPPL. 2 , pp. 51
    • Dressler, D.1    Dirnberger, G.2
  • 9
    • 0033735851 scopus 로고    scopus 로고
    • Complete secondary botulinum toxin therapy failure in blepharospasm
    • Dressler D. Complete secondary botulinum toxin therapy failure in blepharospasm. J Neurol 2000;247:809-10.
    • (2000) J Neurol , vol.247 , pp. 809-810
    • Dressler, D.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.